Ledger.Open graph →
SEC Form D · filed February 16, 2016

Apex Therapeutics, Inc

Offering
$750K
Sold
$750K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
INDIANAPOLIS, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Mark R. Kelly, Phd · Indianapolis, INExec · DirectorJohn R. Barnard · Indianapolis, INDirectorHomer R. Pearce · Indianapolis, INDirectorRoger R. Miller · Indianapolis, INExecDavid R. Broecker · Indianapolis, INExec · DirectorMartin R. Haslanger, Phd · Indianapolis, INDirectorCharles F. Gillies · Woburn, MAExec · DirectorBrian Anderson · Birmingham, ALExec · DirectorHasan Ansari · New Haven, CTDirectorYulia Khvan · New Haven, CTExec · DirectorFanni Li · New Haven, CTExec · DirectorSrikar Prasad · New Haven, CTExec · DirectorKrish Panu · ALAMEDA, CADirectorKenny Lin · Las Vegas, NVDirectorMerav Resistal · Greenwich, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗